Provantage Corporate Finance is pleased to have acted as lead adviser to SPGL on its partnership with CERTANIA, an international Testing, Inspection, Certification and Compliance (TICC) group
The partnership marks a significant milestone in SPGL's growth journey, creating a platform for continued expansion across Europe. As part of the partnership, SPGL will become CERTANIA's European Centre of Excellence for CQV, and GxP Quality Assurance & Compliance services, further strengthening the group's life sciences capabilities and international reach
Amanda Betts commented: "SPGL has built an exceptional business, combining deep technical expertise with a reputation for quality and delivery in a highly specialised sector. This partnership is a testament to the strength of the team, the platform they have created and the growing importance of the services they provide to the life sciences industry. We are delighted to have advised the shareholders on this transaction and look forward to seeing SPGL continue its growth as part of the CERTANIA group"
Sally Saunders added: "TICCs remains one of the most dynamic and attractive sectors in the market, driven by ongoing investment, innovation and increasingly complex regulatory requirements. Businesses with the specialist expertise and reputation that SPGL has developed are in high demand, and this transaction reflects the strategic value of high-quality technical services businesses supporting critical pharmaceutical infrastructure."
Headquartered in London, with an additional offices in Belgium, SPGL is a leading provider of Commissioning, Qualification and Validation (CQV) and GxP Quality Assurance & Compliance services to pharmaceutical and biotechnology manufacturers across Europe. The business has established a market-leading reputation for supporting some of the world's most highly regulated environments, helping clients maintain the highest standards of quality, compliance and patient safety